Shandong Keyuan Pharmaceutical Co., Ltd. (hereinafter referred to as "the Company") and all members of the board of directors guarantee that the content of the information disclosure is true, accurate, and complete, with no false records, misleading statements, or significant omissions.
301281SZSE
Verification Opinions of the Remuneration and Assessment Committee on the List of Reserved Grantees for the 2025 Restricted Stock Incentive Plan
✨ AI Summary
The announcement outlines the verification opinions of the Remuneration and Assessment Committee regarding the list of reserved grantees for the 2025 restricted stock incentive plan. It confirms that all proposed grantees meet the necessary qualifications and do not fall under any disqualifying conditions. The plan is authorized by the board and does not harm the interests of the company or its shareholders.
Summary generated by AI · Always verify with source document
Full Translation
AI Translation· azure_openai
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.